Outcomes of Treatment in Patients with Elderly Postmenopausal Osteoporosis: Comparision of Oral and Parenteral Bisphosphonates
Objective: In this study, we aim to compare the efficacy of oral and parenteral bisphosphonates used in postmenopausal osteoporosis (OP)treatment. Materials and Methods: Between 2010 and 2015, patients older than 65 years who were diagnosed with postmenopausal OP and treated with oral or parenteral...
Main Authors: | Ahmet Aslan, Anıl Gülcü, Ahmet Özmeriç |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2018-08-01
|
Series: | Türk Osteoporoz Dergisi |
Subjects: | |
Online Access: | http://cms.galenos.com.tr/Uploads/Article_19912/TOD-24-53-En.pdf |
Similar Items
-
Intravenous bisphosphonates for postmenopausal osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01) -
Intravenous Bisphosphonates for Postmenopausal Osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01) -
Modern principles for the diagnosis and treatment of postmenopausal osteoporosis: a focus on bisphosphonates
by: I. B. Belyaeva, et al.
Published: (2020-08-01) -
Efficacy and safety of denosumab and teriparatide versus oral bisphosphonates to treat postmenopausal osteoporosis: a systematic review and meta-analysis
by: Jia Yang, et al.
Published: (2024-09-01) -
The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
by: Yilin Zhu, et al.
Published: (2020-05-01)